B700, an albumin-like melanoma-specific antigen, is a vitamin D binding protein.
B700, a murine melanoma-specific antigen, is a member of the serum albumin protein family. Other members include serum albumin and vitamin D binding protein. The primary structure and biochemical functions of B700, as well as its in vivo metabolic fate, are largely unknown. We compared murine albumin, vitamin D binding protein and B700 for their ability to specifically bind [3H]-1,25-dihydroxy-vitamin D3. Scatchard analysis revealed a single binding site for B700 with a Ka of 51,000 mol/l and a Bmax of 4.51 x 10(-7) mol/l. There was no significant difference in the Ka and Bmax among the albuminoid proteins. However, differences in the binding sites could be distinguished by competition experiments where vitamin D3, vitamin D2 or 7-dehydrocholesterol competed for the specific binding of 1.25-dihydroxyvitamin D3 to a greater extent by B700 than by vitamin D binding protein. The albumin binding site more closely resembles vitamin D binding protein than B700, but the data indicate that the binding function of the albuminoid proteins is conserved in B700.
Farzaneh
N K
NK
Department of Pathology, Georgetown University School of Medicine, Washington, D.C. 20007.
Walden
T L
TL
Hearing
V J
VJ
Gersten
D M
DM
D000818:Animals; D000951:Antigens, Neoplasm / Q000378:metabolism*; D001665:Binding Sites; D008546:Melanoma, Experimental / Q000276:immunology / Q000378:metabolism*; D058950:Melanoma-Specific Antigens; D051379:Mice; D009363:Neoplasm Proteins / Q000378:metabolism*; D012709:Serum Albumin / Q000378:metabolism*; D013379:Substrate Specificity; D014809:Vitamin D-Binding Protein / Q000378:metabolism*
D000951:Antigens, Neoplasm; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D012709:Serum Albumin; D014809:Vitamin D-Binding Protein